Back to Search
Start Over
Assessing the links between childhood trauma, C-reactive protein and response to antidepressant treatment in patients with affective disorders.
- Source :
-
European archives of psychiatry and clinical neuroscience [Eur Arch Psychiatry Clin Neurosci] 2021 Oct; Vol. 271 (7), pp. 1331-1341. Date of Electronic Publication: 2021 Mar 17. - Publication Year :
- 2021
-
Abstract
- Adverse Childhood Experiences (ACE) are a well-known risk-factor for depression. Additionally, (high-sensitive) C-reactive Protein (hsCRP) is elevated in subgroups of depressed patients and high following ACE. In this context the literature considers hsCRP and ACE to be associated with treatment resistant depression. With the data being heterogenous, this study aimed to explore the associations of ACE, hsCRP levels and response to antidepressant treatment in uni- and bipolar depression. Nā=ā76 patients diagnosed with uni- or bipolar depression and Nā=ā53 healthy controls were included. Treatment was over 6 weeks in an inpatient psychiatric setting within an observatory study design. Depressive symptoms were assessed by the Montgomery-Asberg Depression Rating Scale (MADRS), ACE were assessed by the Childhood Trauma Questionnaire (CTQ); the body-mass-index (BMI) and hsCRP were measured. HsCRP levels did not differ between the study population and the healthy controls. While the depressive symptoms decreased, the hsCRP levels increased. Sexual abuse was associated with significant higher and emotional abuse with lower levels of hsCRP after 6 weeks. The baseline hsCRP levels and the ACE subgroups did not show significant associations with the treatment response in unipolar depressed patients. The long-lasting effects of specific forms of ACE may have relevant impact on inflammation, supporting hsCRP to be a suitable biomarker. With ACE and hsCRP not showing any significant associations with treatment response in the unipolar depressed subgroup, a more differentiate research concerning biomarkers and treatment regimens is needed when talking about treatment response.<br /> (© 2021. The Author(s).)
- Subjects :
- Biomarkers blood
Case-Control Studies
Depressive Disorder, Treatment-Resistant
Humans
Treatment Outcome
Adverse Childhood Experiences
Antidepressive Agents therapeutic use
Bipolar Disorder blood
Bipolar Disorder drug therapy
C-Reactive Protein analysis
Depressive Disorder blood
Depressive Disorder drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1433-8491
- Volume :
- 271
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- European archives of psychiatry and clinical neuroscience
- Publication Type :
- Academic Journal
- Accession number :
- 33733300
- Full Text :
- https://doi.org/10.1007/s00406-021-01245-z